|
|
IBL027 |
|
Vaxjo ID |
333 |
|
Vaccine Adjuvant Name |
IBL027 |
|
Description |
Immunobiotic Lactobacillus rhamnosus strain IBL027; immunomodulatory strain. |
|
Stage of Development |
Research |
|
Host Species for Testing |
3 |
|
Components |
The genome sequence of the immunomodulatory strain Lactobacillus rhamnosus strain IBL027 |
|
Structure |
Draft Genome Sequence; reads assembled into contigs with a total size 2,898,501 bp. |
|
Function |
The reads were assembled into contigs with a total size 2,898,501 bp. The genome information will be useful for further specific genetic studies of this strain to evaluate its immunomodulatory and biotechnological properties as a vaccine adjuvant. |
| References |
Vizoso-Pinto et al., 2017: Vizoso-Pinto MG, Saavedra L, Hebert EM, Raya Tonetti F, AlbarracÃn L, Alvarez S, Kitazawa H, Villena J. Draft Genome Sequence of Immunobiotic Lactobacillus rhamnosus Strain IBL027, a Potential Adjuvant for Mucosal Vaccine Development. Genome announcements. 2017; 5(50); . [PubMed: 29242218].
|
|
